Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The European Gazette.
Press releases published on May 22, 2025
Great Place to Work® names Openmind Networks one of Ireland’s Best Workplaces in Tech™ 2025
EIN Presswire
·
May 22, 2025
The Best Workplaces in Tech™ list celebrates the innovative, flexible and forward-thinking cultures developed by organisations across Ireland’s tech sector. DUBLIN, IRELAND, May 22, 2025 /EINPresswire.com/ -- Great Place to Work® Ireland has recognised …
Railey Molinario Relationship Intelligence Expert Unveils RI, a Scalable Framework for Building Stronger Human Connections
GlobeNewswire
·
May 22, 2025
London, UK, May 22, 2025 (GLOBE NEWSWIRE) -- Renowned relationship coaching firm Railey Molinario Relationship Intelligence Expert today announced the official launch of RI™️, a pioneering framework designed to help individuals, couples and organizations …
Automotive Oil Market Accelerates Toward Strong Growth with Rising Vehicle Production and Technological Advancements
EIN Presswire
·
May 22, 2025
UK automotive oil market to grow at 2.3% CAGR (2025–2035), driven by rising demand for eco-friendly lubricants and sustainable solutions. NEWARK, DE, UNITED STATES, May 22, 2025 /EINPresswire.com/ -- The automotive oil market is projected to grow at a …
Merus’ Petosemtamab with Pembrolizumab Interim Data Demonstrates Robust Efficacy and Durability in 1L PD-L1+ r/m HNSCC
GlobeNewswire
·
May 22, 2025
- 63% response rate observed among 43 evaluable patients - 79% overall survival rate at 12-months; 9 months median progression-free survival - Conference Call on Thursday, May 22 at 5:30 p.m. ET UTRECHT, The Netherlands and CAMBRIDGE, Mass., May 22, …
PDS Biotech Announces Positive Extended Follow-Up Data for VERSATILE-002 and Additional Trials Evaluating Versamune® HPV to be Presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
GlobeNewswire
·
May 22, 2025
Phase 2: Versamune® HPV with pembrolizumab as 1L treatment of r/m HPV16-positive HNSCC - Median overall survival for CPS ≥20 is 39.3 months - Median overall survival for CPS ≥1 is 30.0 months Phase 3: Versamune® HPV with pembrolizumab as 1L treatment of r/ …
Vertical Farming Global Market Poised for Strong Growth, Predicted to Reach $9.6 Billion in 2025
EIN Presswire
·
May 22, 2025
The Business Research Company’s Vertical Farming Global Market Report 2025 - Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 22, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest Report …
Allogene Therapeutics Announces ASCO 2025 Abstract Publication Featuring Oral Presentation of ALLO-316 in Kidney Cancer and ALPHA3 TIP Poster for Cema-Cel
GlobeNewswire
·
May 22, 2025
SOUTH SAN FRANCISCO, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products for cancer and autoimmune disease, today …
ImCheck Reports High Remission Rates in AML Patients with ICT01 Combination Therapy at ASCO 2025
GlobeNewswire
·
May 22, 2025
ImCheck Reports High Remission Rates in AML Patients with ICT01 Combination Therapy at ASCO 2025 ICT01 in combination with azacitidine and venetoclax (Aza-Ven) achieves unprecedented high remission rates overall and across molecular subtypes in newly …
Boehringer Ingelheim to present early clinical evidence of innate immune modulation and anti-tumor activity via SIRPα blockade in two ongoing trials at ASCO 2025
GlobeNewswire
·
May 22, 2025
· BI 765063 in combination with programmed cell death-1 (PD1) inhibitor antibody ezabenlimab + cetuximab demonstrated a well-tolerated safety profile and potentially promising efficacy signals as second-line treatment in patients with recurrent/ …
Avidicure to Present Preclinical Data from Lead TROP2-targeting Multifunctional Antibody Program at the 2025 American Society of Clinical Oncology Annual Meeting
GlobeNewswire
·
May 22, 2025
AMSTERDAM, May 22, 2025 (GLOBE NEWSWIRE) -- Avidicure, a biotechnology company pioneering an entirely new dual agonistic, multifunctional antibody modality with broad applicability in oncology, today announced its upcoming presentation at the 2025 American …
SABIO DISRUPT LONDON 2025: CX LEADERS SHOWCASE AI INNOVATION AND TRANSFORMATION SUCCESS
EIN Presswire
·
May 22, 2025
Industry giants in CX converged on London this week for Disrupt 2025, the latest leg in Europe's premier digital transformation and innovation programme LONDON, UNITED KINGDOM, May 22, 2025 /EINPresswire.com/ -- Industry giants in customer experience ( …
iConHire: iContactBPO Expands Services to Include Employer of Record Offering for Global Clients
EIN Presswire
·
May 22, 2025
iConHire enables international clients to access specialized skills based in South Africa, through iContactBPO's managed outsourcing framework JOHANNESBURG, SOUTH AFRICA, May 22, 2025 /EINPresswire.com/ -- In a strategic move that reinforces its …
CH4 Global Unleashes Seaweed's Power to Combat Livestock Methane Emissions at Scale
EIN Presswire
·
May 22, 2025
HENDERSON, NV, UNITED STATES, May 22, 2025 /EINPresswire.com/ -- CH4 Global is pioneering the use of Asparagopsis seaweed to dramatically reduce methane emissions from cattle, offering a powerful, nature-based solution to one of agriculture's most …
Zymeworks Announces Presentations Highlighting Breadth of Oncology Portfolio at Upcoming Medical Conferences
GlobeNewswire
·
May 22, 2025
Partner presentations reinforce ability of proprietary Azymetric™ platform to develop clinically validated therapeutic antibodies Long-term outcomes and survival data for Ziihera® (zanidatamab-hrii), which was developed using Azymetric™, to be presented at …
Onconetix, Inc. Announces Receipt of Additional Notice from Nasdaq
GlobeNewswire
·
May 22, 2025
Cincinnati, OH, May 22, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) (the “Company”) announced that it received a Staff delisting letter from The Nasdaq Capital Market (“Nasdaq”) on May 20, 2025 indicating that the Company’s failure to file its …
Divorce-Online Reports Rise in Clients Citing Emotional Attachment to AI Companions as Factor in Divorce
EIN Presswire
·
May 22, 2025
AI Infidelity? Why Some UK Couples Are Splitting Over Virtual Relationships SWINDON, WILTSHIRE, UNITED KINGDOM, May 22, 2025 /EINPresswire.com/ -- UK-based online divorce provider Divorce-Online has reported a notable increase in clients referencing …
From Onboarding to Settlement in Minutes: TransFi Launches BizPay to Redefine Global Business Payments
GlobeNewswire
·
May 22, 2025
TransFi launches BizPay, a unified global payment platform enabling instant, compliant cross-border transactions with AI-powered routing and 250+ local methods across 100+ countries NEW DELHI, May 22, 2025 (GLOBE NEWSWIRE) -- In a world where time zones, …
AeroDelft First Student Team to Test Liquid Hydrogen Aircraft Propulsion System
EIN Presswire
·
May 22, 2025
DELFT, NETHERLANDS, May 22, 2025 /EINPresswire.com/ -- AeroDelft, a fully student-run and student-owned non-profit foundation based in Delft, has become the first student team in the world to design, build, and test an electric aircraft propulsion …
ROKiT and BMW Motorrad Shaping the Future of Motorsport together
EIN Presswire
·
May 22, 2025
BMW Motorrad Motorsport and ROKiT are strengthening their partnership with a focus on nurturing young talent and expanding their international involvement LONDON, UNITED KINGDOM, May 22, 2025 /EINPresswire.com/ -- BMW Motorrad Motorsport and ROKiT …
Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Notice of General Meeting
GlobeNewswire
·
May 22, 2025
May 22, 2025 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Notice of General Meeting Biodexa Pharmaceuticals PLC, (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of …